The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.

The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.

http://www.wikidata.org/entity/Q33360375

about

Autoantibodies in normals--the value of predicting rheumatoid arthritis The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products The role of the complement and the Fc gamma R system in the pathogenesis of arthritis Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia Preclinical systemic lupus erythematosus Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability The systemic nature of the antiphospholipid syndrome.Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients.Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy.The significance and management of thrombocytopenia in antiphospholipid syndrome.ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers.60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.Coherent somatic mutation in autoimmune disease.Patterns of ambulatory medical care utilization and rheumatologist consultation predating the diagnosis of systemic lupus erythematosus: a national population-based study.Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.β2-Glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies.Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features Pathophysiology of the antiphospholipid antibody syndrome.Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort.Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.Competence and competition: the challenge of becoming a long-lived plasma cell.New developments in lupus-associated antiphospholipid syndrome.The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.Predictors of autoimmune disease: autoantibodies and beyond.Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function.Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.Clinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody: A Retrospective Study.Advances in understanding newer autoantibodies and their role as biomarkers in systemic lupus erythematosus.Clinical and serological features distinguish patients with incomplete lupus classification from systemic lupus erythematosus patients and controls.Clinical associations of proinflammatory cytokines, oxidative biomarkers and vitamin D levels in systemic lupus erythematosus.

P2860

Q24798609-1C4143E6-1C1A-435B-B8DE-33F50EE529FF Q24816641-8A6DE3D7-26AB-46D6-9151-965C3E9BB623 Q24817177-30E347D4-2235-4A07-94A9-A4744A725049 Q25257298-EC42076A-07AE-4A01-88BB-DEB5D70A36F8 Q27000666-D3A810F2-782A-4B58-88A4-B03454C8F66C Q27003201-B5A0B42E-2594-4528-8807-013E00A484A6 Q28649846-0B316E84-7E2B-4CF7-8BF8-B0B1F8F0C297 Q33365607-CFDBAC76-AB85-4897-A86D-E91C3114657B Q33377847-6ADD48A5-09BF-4D7A-9798-901F788F3564 Q33394453-0F9F7964-C77F-4C0A-B5FA-7FF4EEEA0E17 Q33394629-5AB62B33-81B8-4E83-8557-4E64ACDBDE48 Q33420910-AD92837D-EA61-488E-A459-39DC9CBC2953 Q33430964-FB3DF12E-E7F5-4086-8455-97023A1C0D57 Q33540161-0F49B86B-3E45-4390-B4F5-96DDE96ADAB7 Q33597476-7C3AD4CB-8081-4604-8BBD-388C423FBB69 Q33837769-5C85D30F-8C8B-4D60-B996-3A6246199A7B Q33855573-7329AC11-58DE-4319-B8C5-AD0211D50FB6 Q33890221-729D4D3A-8845-4B78-A04D-B41E82269FB8 Q34161393-EF457551-26B8-4216-960E-822645C39F68 Q34400681-6F3FB9EE-5B81-4F11-AD04-3C8D28909E84 Q34946314-D5E09509-9A44-433D-A3D3-DFB2AC452D37 Q35126642-45EE7C6A-4F25-4A10-94B8-DD5904329F95 Q35130524-DE93990D-5DF2-476A-AA44-081BF7C2953A Q35146181-4004D79B-FFFE-4B3B-B98C-7A9123BE5719 Q35309024-5833BD24-4DDE-4D60-98CA-CF23418A506D Q35620360-4B2DA8FA-DABA-4121-9FC1-3264501AC150 Q35711767-D81714D7-9F73-49C7-BA7F-1EA8F42CCCB2 Q36227184-B8F025F9-4E59-4546-B405-16A1B972670D Q36228643-78AFCBE3-D5EA-404F-B604-B48BA35DEBC1 Q36375513-DB49652E-10A8-4E2B-97CF-59DC13E8ABCD Q36594883-CE0FF5F9-96FE-4075-97A6-89B30D6F0B07 Q37168035-C818CE0B-A7FA-4C85-AFC1-035FC1B588D2 Q37170754-1254B68D-35C4-472A-8B25-99351805C88D Q37264360-AC188AA8-2D67-4C76-B9DF-9F4C9CB63740 Q37283017-0F643A3D-5740-4F2F-B3F7-74B8E3F0F800 Q37372436-B446772B-33AD-47C3-A979-391DD559380E Q37624092-6E3E8DF4-B040-4194-9E80-C1565AC09726 Q38089261-94E208AF-5AF2-4E90-B973-6EA849E999EB Q38766335-8E5E6397-FF95-4CE6-ABB0-1565354460BE Q38807174-187E0206-B648-4D46-9FF3-A8B96BAC7FA0

P2860

The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.

http://www.wikidata.org/entity/Q33360375

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@ast

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@en

type

label

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@ast

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@en

prefLabel

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@ast

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@en

P1433

Q33360375-45DCDCDD-9A92-4604-B0C8-2D1BC322ADFF

P1476

Q33360375-C65E6736-5B12-4C34-929F-660D20490F00

P2093

Q33360375-0D95BB94-8856-4D4D-AD39-CBFC4D13940E

Q33360375-10281941-0934-451E-A4B2-75F26C952536

Q33360375-61F16098-D6F5-4834-ADDA-A27313BCA617

Q33360375-6847C754-8EC8-42C4-A030-E0AA3ADB6205

Q33360375-C079682F-BBC1-4636-8870-8B6F86C34C43

Q33360375-C2D3A0A1-8F18-4188-A028-6CE32767A447

P2860

Q33360375-71F0C99C-6907-4CEF-8BF7-B8D7D1C222DE

Q33360375-C5CB5FC8-A2AF-4C5A-BB55-212E31A77B3A

P304

Q33360375-A07F7320-63E3-4099-884C-FC0DD4E7F0D4

P31

Q33360375-A3E413CD-E239-4134-8D99-6F1748B959AF

P356

Q33360375-3643FD9D-BB4E-4548-B142-134A966D6E38

P433

Q33360375-275004A5-791E-4662-B737-F9291A054840

P478

Q33360375-2F1282A4-78AF-444F-AA0C-2F01143C36B4

P50

Q33360375-F04D8FF2-30C6-463F-82B0-11F3E3853385

Q33360375-F3DA0257-29B9-42AE-86E1-E982CAD562D6

P577

Q33360375-AEDD1AB6-347B-4E4B-B959-A3DA1659B1DA

P5875

Q33360375-5737B0FA-FB02-4662-98A0-96460179852F

P698

Q33360375-F3831CD3-99DE-4BE6-9F6A-BA0C9698E896

P921

Q33360375-2D5CD37F-B386-40B3-955B-4B941E1E2B6E

P356

P1433

Arthritis & Rheumatology

P1476

The prevalence, onset, and cli ...... systemic lupus erythematosus.

@en

P2093

Gregory J Dennis

http://www.w3.org/2001/XMLSchema#string

Jon Roebuck

http://www.w3.org/2001/XMLSchema#string

Latisha D Heinlen

http://www.w3.org/2001/XMLSchema#string

Mark V Rubertone

http://www.w3.org/2001/XMLSchema#string

Melissa R Arbuckle

http://www.w3.org/2001/XMLSchema#string

Micah T McClain

http://www.w3.org/2001/XMLSchema#string

P2860

Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders.

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.

P304

1226-1232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.20120

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Judith A. James

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8625670

http://www.w3.org/2001/XMLSchema#string

P698

15077305

http://www.w3.org/2001/XMLSchema#string

P921